ABSTRACT The amino acid sequence of human V-trace, a basic microprotein without known function, was determined by automated Edman degradations of the carboxynethylated polypeptide chain and of fragments obtained by cyanogen bromide treatment and tryptic digestion after blocking of lysine residues. The single polypeptide chain contained 120 residues, and the calculated Mr was 13,260. A proline residue at position 3 was partly hydroxylated. The presence of y-trace in a significant proportion of the cells in the anterior lobe of simian and human pituitary glands was demonstrated by immunohistochemical procedures with a rabbit antiserum against human V-trace. The tissue localization and amino acid sequence of V-trace indicated that this protein is connected with the peptidergic gastroenteropancreatic neuroendocrine system. Human y-trace is an alkaline, low Mr protein first described in 1961 as a constituent ofnormal cerebrospinal fluid and of urine from patients with renal failure (1-3). The biological role of ytrace is unknown, although the protein has been shown to occur in low concentration not only in cerebrospinal fluid and urine but also in plasma, saliva, and semen (4-6). A sensitive enzyme immunoassay for measurement of y-trace has been described (7). It allowed quantitation of the protein in all human fluids investigated and demonstrated that, in healthy adults, the concentration of y-trace in cerebrospinal fluid is 5.5 times that in plasma. Recent immunohistochemical studies of y-trace have shown it to be present in some human brain cortical neurons, in adrenal medulla, and in the A cells of the pancreatic islets (8-10). Some amino acid sequence similarities also have been found between human glucagon and the amino-terminal part of y-trace (8). Therefore, the question whether y-trace is related to the peptidergic gastroenteropancreatic neuroendocrine system has arisen. This report describes the complete amino acid sequence of y-trace and presents immunohistochemical evidence of the presence of the protein in a large number of cells in the pituitary gland. Experimental details of the work will be published separately.
Human y-trace is an alkaline, low Mr protein first described in 1961 as a constituent ofnormal cerebrospinal fluid and of urine from patients with renal failure (1) (2) (3) . The biological role of ytrace is unknown, although the protein has been shown to occur in low concentration not only in cerebrospinal fluid and urine but also in plasma, saliva, and semen (4) (5) (6) . A sensitive enzyme immunoassay for measurement of y-trace has been described (7) . It allowed quantitation of the protein in all human fluids investigated and demonstrated that, in healthy adults, the concentration of y-trace in cerebrospinal fluid is 5.5 times that in plasma. Recent immunohistochemical studies of y-trace have shown it to be present in some human brain cortical neurons, in adrenal medulla, and in the A cells of the pancreatic islets (8) (9) (10) . Some amino acid sequence similarities also have been found between human glucagon and the amino-terminal part of y-trace (8) . Therefore, the question whether y-trace is related to the peptidergic gastroenteropancreatic neuroendocrine system has arisen. This report describes the complete amino acid sequence of y-trace and presents immunohistochemical evidence of the presence of the protein in a large number of cells in the pituitary gland. Experimental details of the work will be published separately.
MATERIALS AND METHODS
Isolation of V-Trace. Urine containing about 20 mg of y-trace per liter from patients with renal failure was collected in bottles containing the protease inhibitor benzamidinium chloride and the antimicrobial agent sodium azide. y-Trace was isolated from the pooled urine as described (8) . Its purity was checked by sodium dodecyl sulfate/polyacrylamide gel electrophoresis (11) and agarose gel electrophoresis (12) .
Structural Determination. Isolated y-trace was reduced and carboxymethylated with '4C-labeled reagent in 6 M guanidinium chloride. The carboxymethylated protein was then fragmented by cyanogen bromide treatment (13) or by tryptic digestion after reversible blocking ofamino groups by citraconylation (14) . One ofthe cyanogen bromide fragments (no. 3) was further digested with Staphylococcus aureus V8 protease. On each occasion the fragments were separated by gel chromatography on a column of Sephadex G-50 superfine (1.5 x 190 cm) in 30%
(vol/vol) acetic acid. The absorbance at 280 nm, the radioactivity (14C), and the ninhydrin-reactivity ofthe column fractions were measured. All cyanogen bromide fragments and most of the tryptic peptides were pure after the gel filtration, but some tryptic peptides had to be further purified by preparative highvoltage paper electrophoresis (15) . Amino acid analysis was performed by standard methods (16) after hydrolysis in 6 M HC1. Automated amino acid sequence analysis by the method of Edman and Begg (17) was carried out on a Beckman 890 C sequencer by using the standard Beckman 1 M Quadrol program. All fragments (50-300 nmol) were run in the presence of Polybrene (18) . Phenylthiohydantoin derivatives of amino acids were identified by high-performance liquid chromatography on a 30-cm Waters uBondapak C18 column using stepwise elution with methanol-containing buffers (Waters Associates, internal communication 03-LS-11-76). This detection system identified the phenylthiohydantoin derivatives of hydroxyproline as two peaks at unique positions in the elution diagram. All phenylthiohydantoin derivatives of amino acids were also identified by thin-layer chromatography (19) . Carboxyl-terminal amino acid residues were identified after digestion with carboxypeptidase Y (20) .
Immunohistochemical Procedures. Pituitary glands were taken at operation from a 2.6-kg, 2-year-old adolescent male capuchin monkey, Cebus apella; a 5.9-kg, 13-year-old adult male African green monkey, Cercopithecus aethiops; and, at autopsy 8 hr post mortem, from a 75-year-old man. The specimens were snap-frozen and freeze-dried, vapor-fixed in diethyl pyrocarbonate (21) , and vacuum-embedded in Paraplast (Sherwood Medical Industries, St. Louis, MO). Tissue sections, 2-,um thick, were examined with the Sternberger peroxidase-antiperoxidase technique (22) . A rabbit antiserum against human y-trace was used in the first step ofthe assay. Its production and specificity have been reported (8) , and the precipitating titer according to Becker (23) was 0.19 mg of y-trace per ml of antiserum.
RESULTS
Primary Structure of Human V-Trace. All cyanogen bromide fragments of y-trace and all tryptic peptides of the citraconylated protein were isolated and used in the determination of the complete amino acid sequence (Fig. 1) . The cyanogen bromide fragment 4 was devoid of homoserine and was, therefore, identified as the carboxyl-terminal fragment. The amino acid residues at virtually all positions in the polypeptide chain were identified in at least two different fragments. The proline residue at position 3 was found to be hydroxylated in all three 3024 The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. -%.
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--%. investigated preparations of pure y-trace. Hydroxyproline was identified at position 3, both in the uncleaved polypeptide chain and in the corresponding tryptic and cyanogen bromide fragments thereof. It was demonstrated in all cases both by amino acid analyses and by high-performance liquid chromatography of the corresponding phenylthiohydantoin derivatives. The hydroxylation degree was about 50% but varied slightly in three investigated preparations of y-trace. The polypeptide chain contained 120 residues and had a calculated Mr of 13,260.
When the sequence of y-trace was aligned with known sequences of hormones belonging to the gastroenteropancreatic neuroendocrine system, two similarities were found. Both concerned the 35-residue-long amino-terminal part of y-trace, which showed sequence similarities with human corticotropin (comprising 8 of its 39 residues) and with glucagon (comprising 7 of its 29 residues) (Fig. 2) . The amino acid sequence of human y-trace compared to the sequences of human glucagon (24) and human corticotropin (25) . Identical residues of the molecules are shown in boxes.
antiserum against y-trace, specific antibodies against y-trace, or Clq-depleted native antiserum against y-trace was used (Fig.  3) . No immunostaining was obtained when serum from a nonimmunized rabbit was used. The histochemical immunoreactivity ofthe antiserum against y-trace disappeared after passage "w of the antiserum through a column containing insolubilized ytrace or after absorption of the antiserum with pure soluble ytrace. The immunoreactive end point of serial dilutions of the antiserum was 1:1,600. There was no decrease in the immunoreactivity against y-trace of the antiserum after overnight int. Proc. Nad Acad. (8) (9) (10) . The results of this work show that y-trace also is localized in a large proportion of the cells of the adenohypophysis. These localization studies, taken together, point to a tissue distribution of y-trace, suggesting that it might be a part of the peptidergic gastroenteropancreatic neuroendocrine system. A connection between y-trace and the peptidergic neuroendocrine system is also indicated by the amino acid sequence similarities between human corticotropin, glucagon, and ytrace. 
